<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Systemic therapy for relapsed small cell lung cancer</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Systemic therapy for relapsed small cell lung cancer</h1>
<div class="graphic"><div class="figure"><div class="ttl">Systemic therapy for relapsed small cell lung cancer</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Systemic therapy is typically offered to patients with adequate PS to tolerate toxicities of treatment (eg, ECOG PS 0, 1, or 2). Those with worsened PS, at any point in treatment, are typically offered palliative treatments, which may include pain control, palliative radiation, and/or hospice care.</div><div class="graphic_footnotes">PS: performance status; ECOG: Eastern Cooperative Oncology Group; SCLC: small cell lung cancer.<br/>* Patients with baseline neuropathy, heart failure, hearing loss, renal failure, or frailty (ECOG PS 2 or more) are unlikely to tolerate platinum-based doublet chemotherapy.<br/>¶ Some UpToDate contributors also continue maintenance immunotherapy, along with chemotherapy.<br/>Δ Alternatives include irinotecan or temozolomide.<br/><span class="lozenge">◊</span> Although lurbinectedin has not been directly compared with the camptothecins, it has a milder toxicity profile, and is therefore preferred, if available.<br/>§ Treatment options will depend on what the patient previously received. For example, if the patient has not yet received a camptothecin, this would be the preferred option. A number of other agents, including the taxanes, vinorelbine, gemcitabine, and temozolomide, have shown activity in patients with relapsed SCLC.</div><div id="graphicVersion">Graphic 129498 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
